Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Luke

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1989
Cilastatin-insulin interaction in the ratG C Tompkins, L J Brunner, D R Luke
Antimicrobial Agents and Chemotherapy|November 1, 1996
Safety, toleration, and pharmacokinetics of intravenous azithromycinD R Luke, G Foulds, S F Cohen, et al.
Renal Failure|January 1, 1993
Influence of pentoxifylline on renal function in HIV-seropositive patientsD R Luke, T P Sarnoski, N Bell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1991
Tissue distribution and in vivo immunosuppressive activity of liposomal cyclosporineK Vadiei, G Lopez-Berestein, R Perez-Soler, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1995
Pharmacokinetics of azithromycin in pediatric patients with acute otitis mediaM C Nahata, K I Koranyi, D R Luke, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1992
Failure of predicted creatinine clearance equations in HIV-seropositive patientsB L Smith, T P Sarnoski, S Dennis, et al.
Renal Failure|January 1, 1989
Prevention of cyclosporine-induced nephrotoxicity with pentoxifyllineL J Brunner, K Vadiei, L V Iyer, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1991
Reassessment of dapsone as a marker of acetylator phenotypesE B Wiggan, S Dennis, S B Reele, et al.
Clinical Chemistry|February 1, 1990
Increased sensitivity in a radioimmunoassay for measuring cyclosporine in lipoprotein fractionsL J Brunner, J C Yau, J Lautersztain, et al.
The Journal of Infectious Diseases|March 1, 1990
Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic ratsK M Wasan, K Vadiei, G Lopez-Berestein, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1989
Cilastatin-insulin interaction in the ratG C Tompkins, L J Brunner, D R Luke
Antimicrobial Agents and Chemotherapy|November 1, 1996
Safety, toleration, and pharmacokinetics of intravenous azithromycinD R Luke, G Foulds, S F Cohen, et al.
Renal Failure|January 1, 1993
Influence of pentoxifylline on renal function in HIV-seropositive patientsD R Luke, T P Sarnoski, N Bell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1991
Tissue distribution and in vivo immunosuppressive activity of liposomal cyclosporineK Vadiei, G Lopez-Berestein, R Perez-Soler, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1995
Pharmacokinetics of azithromycin in pediatric patients with acute otitis mediaM C Nahata, K I Koranyi, D R Luke, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1992
Failure of predicted creatinine clearance equations in HIV-seropositive patientsB L Smith, T P Sarnoski, S Dennis, et al.
Renal Failure|January 1, 1989
Prevention of cyclosporine-induced nephrotoxicity with pentoxifyllineL J Brunner, K Vadiei, L V Iyer, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1991
Reassessment of dapsone as a marker of acetylator phenotypesE B Wiggan, S Dennis, S B Reele, et al.
Clinical Chemistry|February 1, 1990
Increased sensitivity in a radioimmunoassay for measuring cyclosporine in lipoprotein fractionsL J Brunner, J C Yau, J Lautersztain, et al.
The Journal of Infectious Diseases|March 1, 1990
Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic ratsK M Wasan, K Vadiei, G Lopez-Berestein, et al.
Pageof 7